Durect's non-opioid painkiller brushes aside checkered past, gaining FDA approval in shoulder surgeries
After a long and often bumpy ride, Durect’s non-opioid painkiller has received the FDA’s endorsement.
US regulators approved the sustained-release bupivacaine solution for use up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.